9. Efficacy and safety of a ready-to-use liquid formulation of abobotulinumtoxinA lyophilisate in moderate to severe glabellar lines: results of a phase 2 randomized, placebo-controlled clinical trial. (January 2015) - Ascher, Benjamin; Kestemont, Philippe; Boineau, Dominique; Bodokh, Isaac; Stein, Annette; Dendorfer, Markus; Heckmann, Marc; Pavicic, Tatjana; Tse, Anissa; Picaut, Philippe; Rzany, Berthold